LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
Selpercatinib, adjuvant, RET fusion-positive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要